Jim Cramer Weighs In On Berkshire Hathaway, Range Resources, Zynerba And More

On Monday's “Mad Money,” Jim Cramer said he remains bearish on Range Resources Corp. (NYSE: RRC) saying natural gas is the weakest part of the petrol chain.

Cramer says although it's speculative, he is bullish on gene sequencing stock Guardant Health Inc (NASDAQ: GH).

He remains bullish on Berkshire Hathaway Inc. Class B (NYSE: BRK-B) and has been recommending the stock since the show began.

Seattle Genetics, Inc. (NASDAQ: SGEN) is a buy, says Cramer.

Cramer says to steer clear of Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) and if you want to play cannabinoids, GW Pharmaceuticals PLC-ADR (NASDAQ: GWPH) is what he would buy.

Related Links:

'Halftime Report' Final Trades From July 16: American Airlines, JetBlue And More

'Fast Money' Traders Talk Retail: Costco, Target And More

See more from Benzinga

• 'Trading Nation' Traders Talk Chipolte, McDonald's And Starbucks

• 3 Stocks Moving In Monday's After-Hours Session

• Whirlpool Reports Q2 Earnings Beat

© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.